Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

NCT06276088 · clinicaltrials.gov ↗
RECRUITING
Status
374
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Nanfang Hospital, Southern Medical University